Comparison of lipid amphotericin B preparations in treating murine zygomycosis.

Autor: Ibrahim AS; Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-University of California--Los Angeles Medical Center, Torrance, CA 90502, USA. ibrahim@labiomed.org, Gebremariam T, Husseiny MI, Stevens DA, Fu Y, Edwards JE Jr, Spellberg B
Jazyk: angličtina
Zdroj: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2008 Apr; Vol. 52 (4), pp. 1573-6. Date of Electronic Publication: 2008 Jan 28.
DOI: 10.1128/AAC.01488-07
Abstrakt: We compared the efficacies of liposomal amphotericin B (LAmB) and an amphotericin B lipid complex (ABLC) in diabetic ketoacidotic (DKA) or neutropenic mice with disseminated zygomycosis. ABLC was as effective as LAmB in neutropenic but not DKA mice. Low-dose ABLC was less effective than LAmB at reducing brain fungal burdens in both models.
Databáze: MEDLINE